Tetrahydropapaveroline and its derivatives inhibit dopamine uptake through dopamine transporter expressed in HEK293 cells

Neuroscience Research

Volumn 30, Issue 1, 1998, Pages 87-90

  Okada, Tomoya ^a   Shimada, Shoichi ^b   Sato, Kohji ^b   Kotake, Yaichiro ^c   Kawai, Hiroshi ^c   Ohta, Shigeru ^c   Tohyama, Masaya ^b   Nishimura, Tsunehiko ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

1 Methyl 4 phenylpyridinium ion; Dopamine transporter; Parkinson's disease; Tetrahydropapaveroline

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; DOPAMINE; DOPAMINE TRANSPORTER; ISOQUINOLINE DERIVATIVE; TETRAHYDROPAPAVEROLINE; TRITIUM;

ARTICLE; CELL LINE; CONTROLLED STUDY; DOPAMINE METABOLISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOASSAY;

ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL LINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; KINETICS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RATS; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDROPAPAVEROLINE; TRANSFECTION;

EID: 0031933355     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(97)00121-1     Document Type: Article

References (26)

1. Cashaw J.L. Tetrahydropapaveroline in brain regions of rats after acute ethanol administration. Alcohol. 10:1993;133-138.
2. Cashaw J.L., Geraghty C.A. Tetrahydropapaveroline and the blood-brain barrier in rats. Alcohol. 8:1991;317-319.
3. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:1987;2745-2751.
4. Davis V.E., Walsh M.J. Alcohol, amines, and alkaloids: a possible biochemical basis for alcohol addiction. Science. 13:1970;1005-1007.
5. Dostert P., Benedetti M.S., Dordain G. Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's disease. J. Neural. Trans. 74:1988;61-74.
6. Dougan D., Wade D., Mearrick P. Effects of L-dopa metabolises at a dopamine receptor suggest a basis for 'on-off' effect in Parkinson's disease. Nature. 254:1975;70-72.
7. Giros B., el Mestikawy S., Bertland L., Caron M.G. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295:1991;149-154.
8. Gray N.M., Cheng B.K., Mick S.J., Lair C.M., Contreras P.C. Phencyclidine-like effect of tetrahydroisoquinoline and related compounds. J. Med. Chem. 32:1989;1242-1248.
9. Heikkila R.E., Nicklas W.J., Vyas I., Duvoisin R.C. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: Implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Neurosci. Lett. 62:1985;389-394.
10. Hirata Y., Minami M., Naoi M., Nagatsu T. Studies on the uptake of N-methylisoquinolinium ion into rat striatal slices using high performance liquid chromatography with fluorimetric detection. J. Chromatog. 503:1990;189-195.
11. Kotake Y., Tasaki Y., Makino Y., Ohta S., Hirobe M. 1-Benzyl 1,2,3,4-tetrahydroisoquinoline as a Parkinsonism-inducing agent: A novel endogenous amine in mouse brain and parkinsonian CSF. J. Neurochem. 65:1995;2633-2638.
12. Kilty J.E., Lorang D., Amara S.G. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science. 254:1991;578-579.
13. Langston J.W., Ballard P., Tetrud J.W. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219:1983;979-980.
14. Maruyama W., Takahashi T., Minami M., Takahashi A., Dostert P., Nagatsu T., Naoi M. Cytotoxicity of dopamine-derived 6,7 dihydroxy-1,2,3,4 tetrahydroisoquinolines. Advances in Neurology. 60:1993;224-230.
15. Matsubara K., Fukushima S., Akane A., Kobayashi S., Shiono H. Increased urinary morphine, codeine and tetrahydropapaveroline in Parkinsonian patient undergoing L-3,4-dihyroxyphenylalanine therapy: A possible biosynthetic pathway of morphine from L-3,4dihydroxyphenylalanine in humans. J. Pharmacol. Exp. Ther. 260:1992;974-978.
16. +) against mitochondria of mouse brain. J. Neurol. Sci. 86:1988;97-110.
17. Nagatsu T., Yoshida M. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci. Lett. 87:1988;178-182.
18. Ohta S., Kohno M., Makino Y., Tachikawa O., Hirobe M. Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline are present in human brain: relation to Parkinson's disease. Biomed. Res. 8:1987;453-456.
19. +. Biochem. Biophys. Res. Commun. 134:1986;743-748.
20. Sandler M., Carter S.B., Hunter K.R, Stern G.M. Tetrahydroisoquinoline alkaloids: in vivo metabolises of L-dopa in man. Nature. 241:1973;439-443.
21. Shimada S., Kitayama S., Lin CL. et al. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science. 254:1991;576-578.
22. Suzuki K., Mizuno Y., Yoshida M. Inhibition of mitochondrial respiration by 1,2,3,4-tetrahydroisoquinoline-like endogenous alkaloids in mouse brain. Neurochem. Res. 15:1990;705-710.
23. Sourkes T.L. Possible new metabolises mediating actions of L-dopa. Nature. 229:1971;413-414.
24. Turner A.J., Baker K.M., Algeri S., Frigerio A., Garattini S. Tetrahydropapaveroline: formation in vivo and in vitro in rat brain. Life Sci. 14:1974;2247-2257.
25. Usdin T.B., Mezey E., Chen C., Brownstein M.J., Hoffman B.J. Cloning of the cocaine-sensitive bovine dopamine transporter. Proc. Natl. Acad. Sci. USA. 88:1991;11168-11171.
26. Yamato E., Hirakura M., Sugasawa S. Synthesis of 6,7 dihydroxy-1,2,3,4-tetrahydroisoquinoline derivatives. Tetrahedron. Suppl 8:1996;129-134.